Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure

NCT03758625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: a1DC + inactivated whole autologous HIV
BIOLOGICAL: a1DC + conserved HIV peptides
BIOLOGICAL: a1DC + no antigen
BIOLOGICAL: pgDC + inactivated whole autologous HIV
BIOLOGICAL: pgDC + conserved HIV peptides
BIOLOGICAL: pgDC + no antigen

Sponsor

Sharon Riddler

Collaborators

[object Object]